Tyrosine hydroxylase (TH) is a key gene in the dopamine system as it is the rate-limiting enzyme for dopamine (DA) synthesis, alterations in this gene have been observed in patients with depression, and have led to investigations focused on targeting TH as a novel therapeutic treatment for mood disorders43–45. This evidence concerns the gene TH and depressive symptom measurement.